Welcome Dr. Behzad Mahdavi

Dr. Mahdavi brings more than 20 years of experience in developing and leading innovative strategies in the sector

Ginkgo is excited to welcome Behzad Mahdavi, Ph.D., MBA, as senior vice president of biopharma manufacturing and life sciences tools. In this new role, Dr. Mahdavi will lead our commercial efforts in the growing areas of bio-reagents, cell and gene therapies and new biopharmaceutical modalities. Dr. Mahdavi brings more than 20 years of experience in developing and leading innovative patient-centric growth strategies in challenging environments in the biopharmaceutical, cell and gene therapy, personalized medicine and life sciences sectors.

Dr. Mahdavi brings outstanding experience in global business growth, expansion and commercial innovation, which will be instrumental as we aim to redefine the landscape of treating diseases. We’ve proven how much our platform can help newcomers and incumbents in the growing biopharma space. As we continue to evolve our horizontal platform applications, having Dr. Mahdavi on our team will strengthen our ability to deliver innovative services to our customers and we can’t wait to onboard more programs in the coming months and years.

To discuss how you can leverage Ginkgo’s biopharma and life science capabilities, sign up for Ginkgo Office Hours to speak with our team today!

Dr. Mahdavi is joining a team that has significant experience in designing custom organisms and discovery of novel enzymes that bring new biopharma products to life. Ginkgo’s robust codebase and ability to search and screen candidates in silico and in vitro in high throughput allows it to support programs across all aspects of biopharma manufacturing and discovery. Our projects in this space span our expertise with both microbial and mammalian cells, and include publicly announced collaborations with Antheia, Aldevron, Biogen, Microba, Moderna, Novo Nordisk, Optimvia, Persephone, SaponiQx, Selecta Biosciences, Synlogic, Tantu, Totient, and Roche, as well as additional programs at various stages in the pipeline. With our strong enzyme discovery, optimization and metabolic engineering capabilities, we hope to enable the creation and improvement of product development across all therapeutic modalities.

“Ginkgo is integrating capabilities at massive scale in genetic engineering, manufacturing process optimization and bioinformatics along with innovative technologies from third-party developers,” said Dr. Mahdavi. “There are a tremendous number of opportunities in this space, and I joined Ginkgo because I believe this company is the partner of choice that the industry needs to realize those boundless opportunities. I am thrilled to work alongside Ginkgo’s world-class team to help create a platform of choice for our partners who strive to benefit patients around the world.”

Dr. Mahdavi most recently served as vice president of global open innovation at Catalent Pharma Solutions, where he created a distinctive portfolio of innovative services and expanded its customer base in new market segments. Prior to his work at Catalent, he held numerous leadership positions during his 13 years at Lonza and served as CEO of SAM Electron Technologies. Throughout his career, Dr. Mahdavi has built expertise in defining and developing optimal growth strategies and actionable business plans across biologics, cell therapy, and viral pharmaceutical modalities. In addition to his company leadership roles, he has also served in multiple Board of Directors and Advisory Board roles. Dr. Mahdavi holds a Doctorate in Chemistry from the University of Sherbrooke, Canada, and also has a Master in Business Administration from the University of Quebec in Montreal.

To discuss how you can leverage Ginkgo’s biopharma and life science capabilities, sign up for Ginkgo Office Hours to speak with our team today!

Find the full press release here along with all of the latest news from the Ginkgo team.

What will you grow with Ginkgo?

Day in the Life of Kristen, Automation Engineer

We’re excited for our next interview in our day-in-the-life series! Here we hear from Kristen Tran, one of Ginkgo’s first ever Automation Engineers, on her path to Ginkgo and what she’s looking forward to in 2020. 

How did you find this industry and this role? What was your path to Ginkgo?

Both my undergraduate and graduate degrees are in biomedical engineering. I did my undergrad at the University of Texas, then came to Boston for graduate school at Boston University. After graduating from BU, I was at a networking event for women in science and engineering, and connected with a manager at Merck Pharmaceuticals, who asked me a question I’d never considered—was I interested in automation?

As it turns out, I was very interested, and my career as an automation engineer began! I already had a solid base of engineering knowledge from my education, but I built my expertise in lab automation through hands-on work. I had been at Merck for about 6 years when a friend of mine, who was working at Ginkgo, got in touch about the company’s automation team—which at that time was just one person (Jeff Lou, still our head of automation today!)—and I realized I had found my next step.

I was really excited about the prospect of building something new, and between that, and all the amazing things the company was working on, I was sold, and joined Ginkgo back in 2015 as the first member of the automation team. These days, we are a team of 13 and growing!

What is the automation team’s role and impact at Ginkgo? 

Our team is in charge of automating manual processes within Ginkgo’s foundries. This means lifting all kinds of manual work off of our foundry engineers in the lab—not only automating processes they would normally need to do by hand, but also helping them to scale processes beyond human capacity, processing thousands of samples each day at nanoliter scale.

This is important work because it gives our foundry engineers more time to do what’s really valuable for them—developing new tools and processes to engineer biology. For instance, we were able to program our acoustic liquid handler to perform 2D full factorial experiments to optimize how we sequence our engineered microbes.

We do this by designing and implementing custom system integrations combining off the shelf and custom hardware and software elements—enabling our foundry engineers to program and execute personalized protocols on our automated systems.

How does the automation team at Ginkgo operate, and what is your role within the team? 

On the automation team at Ginkgo, everyone does a little bit of everything. We’re very cross-disciplinary, working across hardware, software and biological process implementation. That said, we all have different strengths—largely due to the fact that we all come from different engineering backgrounds. On the team now, we have mechanical engineers, an aerospace engineer, chemical engineers, and biomedical engineers. There are some team members that came to Ginkgo right out of school, other industries, or have been working in the lab automation space for years. It’s really this mix of expertise and career backgrounds that allows the team to operate so effectively.

As the most senior member on the team, I tend to play a more strategic role in guiding and overseeing projects that come in. I also serve as a liaison between our team and all the other teams at Ginkgo—a part of my job I really enjoy, because it gives me a holistic view of everything the company is working on and where my team can help. Along with this higher level work I still very much get my hands dirty on ongoing projects, contributing directly on engineering implementation and helping to configure and design new systems, while also supporting our current systems.

While it’s not necessarily part of my job description, I’m also heavily involved in our hiring process, because I believe that at the end of the day, our strongest asset is our team. Making sure that we have the strongest, most diverse team of engineers that we can so that we continue to scale that team and deliver the best results for Ginkgo is incredibly important.

What does your day-to-day look like?

A typical day varies! It can involve anything from troubleshooting specific instruments or processes, working hands-on in the lab, installing or optimizing software or hardware—to longer-term work, working on the design and architecture of future projects. There are so many different implementation and design aspects to this job.

There’s an operations aspect as well, making sure that people understand what our platforms are capable of, training new users and helping with any issues they might have. We need to understand on an operations level if there is anything that we need to improve, and help our teams to make the most of the platforms we design and implement.

What is your favorite part of your job, or what makes you the most excited?

So for me, personally, one of my favorite things is that this job creates a lot of opportunities for variety and cross-disciplinary challenges. Since a day is so variable, there are always new problems to solve.

Another thing I love about this particular role and this team is that, because we’re a core infrastructure team at Ginkgo, I get to work with basically everyone at the company, from the foundry teams to business development and project leads. Not only does this give our team the opportunity to discover and drive efficiencies across the business, we also get a front row seat to all the latest developments across teams—an early look at the latest and greatest at Ginkgo.

The automation team is able to, within the course of our regular work, develop a truly holistic view of the company. This gives us a unique opportunity to understand how all the pieces of the puzzle that is Ginkgo fit together.

What is Ginkgo working on that you’re most excited about?

I honestly can’t name one specific project! What really excites me is that Ginkgo is working on a more diverse set of projects and problems than almost anyone else out there, whether from a customer perspective or a platform perspective. And we’re constantly working to expand the scope and complexity of the problems and challenges we tackle.

One goal of our team specifically is to help build the most flexible platform we can here at Ginkgo, that can both scale AND adapt —and that’s incredibly exciting. You don’t often see both of those factors combined and for us, it’s a key focus, and one that is critical to Ginkgo’s success.

What is one of your goals for 2020?

I would love to see more diverse applicants applying for our team—both in terms of their career  backgrounds (spoiler alert: you don’t have to be a synthetic biologist to work here!) and individual experience. Ginkgo welcomes and celebrates diversity of all kinds and frankly, we’re a stronger company for that.

To apply to our automation team, head over here.

Day in the Life of Software, Whimsy, and Dan

As a part of our “meet the Ginkgo team” series, today we’re featuring a chat with Dan Cahoon, a software engineer (or, software Jedi). Curious how a software engineer ends up working in biology? Read on:

Tell us a little more about your background and what brought you to Ginkgo:

I was a chemistry and biology major in college – but I ended up taking some computer science classes my sophomore year because they counted toward my major. Those ended up being my favorite classes, and I soon figured out I liked coding more than I liked being in the lab, so I went on to minor in computer science. After graduation I was looking for jobs that could combine biology and computer science. Someone in my lab had met one of Ginkgo’s founders (Jason) and connected us, and I’ve been at Ginkgo ever since.

I’ve actually been at Ginkgo longer than anyone besides the founders; they gave me the chance to develop my skills, and believed in me from the start so I could really hit the ground running and apply my biology knowledge to work on some pretty fascinating problems.

What’s your high-level impact at Ginkgo?

It has changed a lot over the years but in short: to make biology easy to engineer, you have to be able to create repeatable engineering experiments. That requires scaling up beyond what you could normally do with just a person working on their own. So I work with our sample tracking system to track what happens in the lab and enable robotic automation and automated data analysis. That process gives our organism engineers superpowers: they can do 1,000 times as many experiments as they would with manual processes.

What’s your typical day like?

I bike into work, and my first task is to sit down in our design studio and code for a few hours. After lunch I’ll have planning meetings or one-on-one check-ins with team members to make sure they’re making progress, have a good idea of what they should be doing and how to do it, and most importantly that they’re happy. We’ll cover things like backlogs and priorities so we can figure out how long various projects will take and commit to getting features rolled out in a timely manner.

Right now my team is creating a link between our sample tracking software and a new automation software, so that we can capture what’s happening on our robotic platforms and not have to manually enter all that information. We’re also building the front end to allow users to specify what their experiments are and then run them on our robotic automation platform.

What’s the most unique part of your day-to-day?

Aside from the software developer side of things, I’m the “Chief Whimsy Officer” at Ginkgo. The role is really about ensuring that we’re having fun while we tackle some really important problems. Creating a culture of whimsy lets people be comfortable coming to work as themselves,  and encourages a happy and safe environment. If people are engaged in their work and feel they can express themselves, they will be better at their jobs and be more productive. It’s just common sense: if somebody is miserable they’ll do the bare minimum. But if you know your day is going to be fun, you’re going to want to show up and do your best work.

I help make sure we’re doing silly things like holding “whimsy office hours” where we can play VR games and make new Slack emoji.  I try to allocate some time out of every week for things like this, because it’s a big part of Ginkgo’s culture to be silly and whimsical. My dream is to run a model train between the foundries to deliver plates of samples around. It’s a system we do need, but I like the idea of bringing in a whimsical touch.

Again, being a software developer at a biology company seems pretty unique. How would you explain your job to other developers?

We’re still serious engineers. Ginkgo is using a lot of cutting-edge developer tools, like React and GraphQL and our developers write Ruby, Javascript and Python. Our software stack has grown tremendously because all our developers are encouraged to evaluate new tech and bring it on board.

At the same time, it’s unique because we’re working on some really powerful science, doing things that have never been done before, and being a part of that is incredible. At Ginkgo, you’re working on something that’s going to change the world, which is more interesting than programming for adtech or changing Google’s search algorithm to be slightly faster. Those things are important, but can’t compare to terraforming Mars with synthetic biology or bringing back the scent of an extinct flower. There’s nowhere else in the world where things like this  are happening on a daily basis, and knowing Ginkgo’s incredible work is propelled by the software I wrote is the greatest part of my job.

Day in the Life: Chris, Software Engineer

In the latest edition of our day-in-the-life series, we hear from Chris Mitchell, Software Engineer about his journey to the engineering team at Ginkgo Bioworks.

How did you become involved in your industry and what led you to work with Ginkgo on the software engineering side?

I actually don’t have a formal education in computer science. I earned my Ph.D. in Biochemistry, Cellular and Molecular Biology from Johns Hopkins and I’ve been a self-taught programmer since the age of 16. Throughout my academic career in the sciences, I spent a lot of time in the lab and became closely acquainted with the huge amount of data and repetitive manual tasks that come with running experiments. For me, software was the perfect way to bridge two worlds I was closely ingrained in to solve some major inefficiencies I was experiencing first hand in the lab. I landed at Ginkgo after someone from the company found my GitHub page and saw some of the tools I was building – new analytical tools for mass spectrometry and sequencing data, as well as a project to enable reproducible data science. After meeting the team at Ginkgo, I was blown away at how quickly they understood the nuances of my work and the caliber of the team. So began my formal entry as a software engineer in the life sciences.

Tell us a little about your role and the impact you have at Ginkgo.

On a fundamental level, Ginkgo could not exist if it weren’t for automation, and automation can’t exist without software. Thanks to the level of automation Ginkgo has brought to the lab, we’ve reached new heights in scale, iteration, data and reproducibility in the synthetic biology industry.

The software engineering team at Ginkgo works with people across a number of different areas, including product management, lab work, analytical pipelines, sales and more. Software is the underlying technology that allows our platform for organism design to operate at such a scale, so it’s essential that we are constantly communicating with every team to ensure things are running smoothly, we’re addressing bottlenecks quickly, and building for the future.

To illustrate how the engineering team’s work affects the larger mission at Ginkgo, I can share a little about one of the projects I’m working on right now. We’re currently working to find a better way for our different users to interact with sequencing data. Sequencing data is used at nearly every stage at Ginkgo: the DNA Fabrication team uses it to verify synthesized sequences, the Build team uses it to verify strain constructs, and the Test team uses it to understand how the transcriptome and other genomic elements contribute to a given phenotype. There are also other indirect users such as data scientists trying to build models to improve future engineering efforts.

Thus, we have a diversity of users – some work with 10,000 samples and some only work with 3-4. It’s really challenging to build a UI and analytical capabilities that capture both ends of the scale in an accurate and consistent way but it is incredibly important. Users need to make informed decisions with as little margin of error. To enable that, we need to build software that permits quick, global insights into their data but also provides the ability to drill down to the most basic elements of a given data type. Users also need to be able to analyze and refine parameters
without rerunning entire workflows that can take hours to complete.

Many people would probably be surprised to hear that you’re a software engineer at a biology company rather than a tech company – what’s that experience been like for you?

A common problem for any software is being built on legacy infrastructure that makes it hard to adapt as technology evolves. Luckily, Ginkgo’s founding team made some smart decisions early on about which stacks we’d build the technology on and we’re continuing to reap the benefits on the developer side. Since then, the leadership and culture at Ginkgo has continued to embrace change and as a developer, I feel empowered to explore and implement new technologies.

For instance, when I came to Ginkgo we were using VMs to run our applications and now we are entirely Docker-based. Similarly, all our UI development is now in React and GraphQL to stitch our data together. These choices have made it so we can standardize the developer experience in terms of spinning up services but still allow some exploration on the underlying tech stack. For example, we have microservices written in Ruby on Rails, Django, Node and Go, which largely were chosen on the basis that the language was the best suited for the particular microservice’s task.

On a more philosophical level, part of the reason why I love working on Ginkgo’s engineering team is that we are building an entirely new frontier. So much of today’s developer role is focused on making something run a half a second faster or increasing ad engagements by 2 percent. Instead, I get to apply those same frameworks and technologies to solve novel problems in synthetic biology, like how to predict the metabolic network for a piece of genetic code.

How have you seen the role of the developer evolve?

The biggest change I’ve seen over the years is a stronger desire from developers and engineers to want to leave a lasting legacy with their work. People in this industry are realizing the power and importance of the technology they work with and want to put those efforts toward bigger problems that can change the world. You’re starting to see developers looking for opportunities where they can have a larger impact and applying their skills to solve big problems in healthcare, sustainability, autonomous vehicles and more.

Day in the Life of Dawn Thompson and NGS

Photo Credit: Grace Chuang



Today, in our series exploring the day-to-day lives and interests of Ginkgo employees, we talk with Dawn Thompson, Head of Next Generation Sequencing and Senior Biological Engineer at Ginkgo.



How did you become involved in your industry? Tell us a little bit about your background and the path that brought you to Ginkgo.

I’m a biologist primarily because I love understanding how things work. I’m a geneticist, with the bulk of my training in genomics. The most exciting thing about genomics to me is understanding how the DNA in your genome gets translated into particular characteristics, and how the contents of your genome can be decoded to determine what makes you, you. Of course, people are really complicated, from a DNA perspective, so the simplest way to practice genomics is to look at a simple organism. That’s why I decided to focus on microbial biology. Microbes are fascinating; they live everywhere on the planet — glaciers, volcanoes, even on us — and they do all these fantastic things.

When I was just starting out as a geneticist in graduate school, I was studying one gene at a time, but I knew to really work in genomics I would need to understand entire genomes. I joined the Broad Institute, an arm of MIT and Harvard that was launched in 2004 to improve human health using genomics, and worked there for 9 years studying genomes and their characteristics.

I loved my time at the Broad Institute, but every 10 years or so, I like to look at my career and think: What other cool stuff is there to learn in biology that I haven’t explored yet? To me, synthetic biology was the obvious next step. Synthesizing DNA was getting cheaper, as was sequencing, meaning we could now both “write” (synthesize) and read (sequence) genes in a cheap, high-throughput way. That opened up all kinds of ways to use synthetic biology to understand the functions of cells and program them to serve new functions.

Ginkgo Bioworks was the perfect opportunity to explore synthetic biology and combine my interest in microbes, my expertise in evolution and genomics, and my passion for understanding how things work on a biological level. This August, I’ll be celebrating three years there, leading out next generation sequencing team.

Tell us a little about your role –  what’s the high-level impact you have on Ginkgo?

Ginkgo is divided into two primary departments, foundry teams and customer-facing teams, and as part of my role as a senior biological engineer I’m involved in both sides of the business.

My primary responsibilities are on the foundry side, providing services and support for internal Ginkgo teams and helping our organism engineers determine which of our organism designs are working the best. To do this, my team and I leverage Ginkgo’s next generation sequencing platform (which I played a primary role in creating), allowing the organism engineers to sequence the constructs they use in their organism engineering and sequencing those organisms so that the engineering teams can understand their genomic sequence and ultimately design them.

My team is about 10 people right now, a mix of scientists handling the gene sequencing and bio-mathematicians who can analyze the resulting data.

Photo Credit: Tim Llewellyn

When Ginkgo takes on a new project, we often have a new microbe that we want to work in. My team is one of the first steps in that process. We call it “onboarding a new host organism.” Typically, we can design something on the computer and understand what the sequence will be. But in order to do that, you need to first understand the full genomic sequence of an organism. So for new host organisms we’ll do a custom project where we do several types of sequencing, a lot of computational analysis and then generate what’s called the “reference genome” for them. It’s a really collaborative process.

A real benefit Ginkgo — and our team specifically — offers to our internal engineers is that, because of our next generation mix of automation, we can do all of this in high throughput work cheaply and quickly, speeding up the overall engineering cycle and get answers fast.

Photo Credit: Tim Llewellyn

What’s most exciting to you about the work Ginkgo is doing right now?

Our new agtech company Joyn is super cool. About 15 years ago I was trying to figure out my career, and was fascinated by the idea of going out in the field to sequence organisms in the oceans and soil. Now that’s actually some of the work we’re doing with Joyn as we try to figure out how to engineer a microbe that can live in the soil and help plants grow, replacing nitrogen fertilizer with a more “green” process.

Our tagline is, we’re trying to make biology easier to engineer. In order to do that, we need to understand biology better — and identify the common themes and designs that will help speed up our process.

That will allow us to replace a really labor-intensive, expensive, resource-demanding process with something very green. You can make a lot of stuff both cheaply, and not use a lot of resources that create problems with waste that you need to dispose of. Biomanufacturing is a very cool green process.

Mother nature is the best engineer! If we source all the biodiversity in nature and understand what’s in the genomes in those organisms, it opens up a wide range of functionality. Ginkgo is well on its way to demonstrate that this is a technology that is not only here to stay but can be leveraged to create anything — to make textiles, to replace plastics. If we do it right, we don’t need petroleum based plastics anymore!

Photo Credit: Tim Llewellyn

What do you love most about your job?

It’s hard to pick just one thing, but one of the things I love the most about my work at Ginkgo is that we are using state-of-the art methods to interrogate so many aspects of cellular function. Our sophisticated automation allows us to do this at scale, taking a holistic approach to organism engineering. This is a powerful and versatile way to create organisms for our customers; the resources at Ginkgo allows us to interrogate biology in a way we haven’t be able to previously. We can understand biology on an entirely new level and in turn identify common themes or design principles that can be then be used for a wide variety of applications. It’s almost limitless.

Day in the Life: Emily Greenhagen

Credit: Justin Knight


Today we’re introducing a new series that will help you get to know our Ginkgo employees a little better, and share more information on what happens behind the scenes in our foundries and beyond. First up, we’re going “behind the biotech” with Emily Greenhagen, our Head of Deployment.



How did you get involved in your industry? Tell us a little bit about your background and the path that brought you to Ginkgo.

I earned my bachelor’s degree in biology from MIT. As an undergrad, I worked on cancer research and while it was really interesting, over time I realized that even though I’m trained as a scientist, I’m more motivated by applying the research. I want to make an impact on the world in my lifetime. That led me to a job as an organism engineer at Microbia, where I was then able to learn how to validate strain performance in a bioreactor. Learning fermentation changed by entire vision: I felt like it was my calling!

I love fermentation – it’s at the crossroads of science and engineering: you need to understand both the microbial physiology and the physical nature of the environment – the heat transfer, the mass transfer. That was really exciting. I was working in an area that combines two areas I really love, and working on a process that produced something really impactful in a renewable way. As I learned more about the industry, I realized how many products in our everyday lives are produced from fermentation as a manufacturing process – it blew my mind. And helped me realize the impact I could have with this technology.

I’ve been at Ginkgo for about three years. We’re developing interesting products, but more importantly, we’re perfecting this high-throughput automated technology that will enable us to more efficiently and effectively solve the world’s problems…while doing a bunch of fun stuff in the meantime! If we’re doing it right, we’re building a system that will be hugely impactful.

Tell us a little about your role –  what’s the high-level impact you have on Ginkgo?

Three years ago Ginkgo was “the organism company,” and I was brought on to build out the fermentation team so that we could also provide our customers with industrially relevant fermentation processes for the organisms we were engineering. My first project was our first commercial product with Robertet.

Now we have an amazing lab-scale setup that I’m really proud of, an awesome team, and about 15 projects being actively worked on by the fermentation team– it’s a team that’s really scaled with Ginkgo.  The success of projects we worked on in fermentation meant that I got a crash course in everything from regulatory to safety and supply chain management.

As we moved our first product toward commercial scale, it became evident that it would benefit Ginkgo and our customers if we had the internal capability to also manage commercial production when that option makes sense for Ginkgo and our customers. So, last summer I transitioned from fermentation to deployment. In the foundry, we have awesome tools that take care of R&D, but once you have your strain and fermentation process developed, there are a lot of tools we need to take that to a contract manufacturer, ensure we can scale it up, meet our cost goals and product spec, etc. So deployment is where we break away from the foundry model and make it commercializable.

Before I came to Ginkgo I didn’t think fermentation could be done in high throughput. But now we’ve validated some really amazing technology that can increase the throughput of each fermentation engineer four to six times. Based on our success in fermentation, I’m optimistic we can also find ways to carry some of the foundry efficiencies downstream into the deployment functions, too.

Walk us through a typical day in the lab/your role

A lot of meetings! Right now, I’m working with a contract manufacturer to install additional downstream capacity. We are able to run 50,000 liter fermentations and purify crude product, but don’t currently have the capacity installed to purify the final product. So I spent today discussing the capital installation at our contract manufacturer, reviewing timelines, managing resources, and then had lunch with one of my best friends who also happens to work at Ginkgo! Then I worked on performance reviews, met with some other project leads, and had a meeting about shipping safety requirements.

What’s the most exciting thing Ginkgo is doing?

I have kids, so I think about how I can contribute to making the world a better place for them and future generations. I’d love to make products that are renewable, sustainable, and biodegradable.

I get really excited about Ginkgo in general. We’re taking things to the next level! This technology — biology — can provide so much more for humanity than we currently utilize. Joyn Bio is Ginkgo’s first major venture that could impact our use of fossil fuels and overall health of the plant. I’m not directly involved in Joyn, but it’s a huge dream and if anyone is going to deliver on it, we have the best chance of success. I get goosebumps just thinking about it.

2017 So Far:  Growing our Technology & Our Team

2017 So Far:  Growing our Technology & Our Team
Jason Kelly, Ginkgo Bioworks co-founder and CEO

The first half of 2017 has been nothing short of incredible for Ginkgo. We acquired Gen9 in January to bring their DNA synthesis capabilities in-house, and last month announced successful commercial-scale fermentation of an ingredient with our partner Robertet. Both of these were significant milestones in our work on continuing to scale our technology, but we know there’s more work to do.

Today, we’re officially announcing two new additions to our team here at Ginkgo who will play a huge role in our ability to continue to scale: Ena Cratsenburg, our chief business officer, and Will Schroeder, head of metabolic engineering. Ena has over a decade of business development experience in biotech, but also spent more than five years with Pixar.  She’s already brought that mix of practical experience and outside-the-box thinking to her role overseeing new partnerships and the commercialization of our tech and products. You can read more about Ena’s day-to-day experience at Ginkgo here, and how she found her way from Pixar to biotech.

Will serves as our new head of metabolic engineering, managing the teams of organism engineers designing the microbes that produce cultured ingredients for our customers. He comes to us from ADM and spent 12 years at Cargill. Both of these companies are partners of ours, and it’s great to have Will’s unique understanding of the industry and incredible expertise in enzymes (he’s the author or inventor of 16 publications and patents in the areas of microbial fermentation, molecular biology and enzyme catalysis!).

Please join me in welcoming Will and Ena to the team! You can read more about our commitment to diversity in our hiring practices here, and see open job recs here.

Employee Spotlight


Ena Cratsenburg is the Chief Business Officer at Ginkgo Bioworks and has more than a decade of experience working in the industry with companies like Amyris, Evolva, Intrexon and Pixar. Get to know Ena a little better and learn more about her role at Ginkgo:

1. Can you tell us about your career journey and how you went from Pixar to the biotech industry?
I spent six years at Pixar overseeing the Disney/Pixar collaboration and doing deals that would maximize the value of Pixar’s intellectual properties. When I joined Pixar in ‘99, they had just signed the Co-development Agreement with Disney (which was essentially a 50/50 partnership), and I was responsible for making sure the agreement was implemented properly which included ensuring Pixar properties were monetized in the market to the fullest extent. For example, I was actively involved with Disney’s television team to determine the best way to license the Pixar films for television distribution across geographies and different distribution windows (e.g. PPV, cable, network, etc.). In addition to the Disney agreement, Pixar carved out rights to exploit its IP in interactive games. As the only business person on the team at the time when I joined Pixar, I also worked on the deals related to licensing of the Pixar properties to interactive gaming companies.

Surprising as it may sound, this was the perfect training ground for me to make an entrance to the biotech world at Amyris, Evolva, Intrexon and now Ginkgo. It laid the foundation for understanding how to commercialize emerging technologies and identify market opportunities. I had always been attracted to synthetic biology for its potential to revolutionize technology and was excited to join the industry to help companies recognize the power of microorganisms and find a competitive edge within biology.

2. Why Ginkgo?
The two main drivers for my move to Ginkgo were the technology and the team. Ginkgo’s technology is infinitely scalable and Ginkgo’s incorporation of automation into its foundry expands the universe of what is possible with synthetic biology. Furthermore, Ginkgo’s technology and foundry model make engineering biology far more economically sound – something that’s always top of mind for me on the business development side. The team at Ginkgo is incredibly smart and it’s exciting to work amongst such a talented team. Beyond just the technology and high-quality deal flow the team is bringing in, I’ve noticed how well everyone articulates Ginkgo’s mission and value proposition. I can’t imagine a better team.

3. What does your role entail at Ginkgo?
I oversee business development at Ginkgo, working closely with our customers, partners and prospects to help them identify new ways to leverage synthetic biology in their line of business. My focus has always been on commercializing emerging technologies, and at Ginkgo that means helping companies understand the greater potential of synthetic biology whether that means finding ways we can utilize biology as a platform for new product development, supporting production and cost efficiencies, or promoting sustainability. As far as day-to-day, there is really no standard day for me. I could be developing new value propositions, meeting with customers (either via telephone or in person), furthering various stages of our pipeline, or negotiating/evaluating deals. I also work closely with the business development team to provide guidance and support as needed.

4. Can you discuss your experience working in the consumer sector as it relates to synthetic biology?
I led the consumer sector at Intrexon and was responsible for identifying opportunities to connect consumer-oriented companies with Intrexon’s existing technologies. Between my time at Intrexon and now with this role at Ginkgo, I’m thinking more critically than ever about how synthetic biology can impact consumer goods outside of just ingredients, chemicals or biofuels (which have been the focus of synthetic biology companies thus far). Ginkgo’s technology allows me take a step back and look broadly at the societal, economic and environmental impact that synthetic biology can have on products that consumers engage with every day like cosmetics, fermented foods, wearable devices, clothing and more. These are areas that synthetic biology has only now begun to explore.

5. What is your favorite thing about working at Ginkgo?
Hmmm, I actually have two things. The first is that I love the “swing for the fences” mentality. I truly believe that in order to do big and impactful things, we have to think big and be willing to take the risks. Ginkgo embraces that and I love how this mentality is woven into the company’s DNA. The second thing is the commitment and dedication of the team – we have incredibly talented and smart folks here, and when we combine that with commitment and dedication, we are unstoppable!